Brainsway Stock Alpha and Beta Analysis

BWAY Stock  USD 9.87  0.19  1.96%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Brainsway. It also helps investors analyze the systematic and unsystematic risks associated with investing in Brainsway over a specified time horizon. Remember, high Brainsway's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Brainsway's market risk premium analysis include:
Beta
1.24
Alpha
0.23
Risk
3.43
Sharpe Ratio
0.15
Expected Return
0.5
Please note that although Brainsway alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Brainsway did 0.23  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Brainsway stock's relative risk over its benchmark. Brainsway has a beta of 1.24  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Brainsway will likely underperform. Book Value Per Share is likely to drop to 1.62 in 2024. Tangible Book Value Per Share is likely to drop to 1.62 in 2024.

Enterprise Value

74.99 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Brainsway Backtesting, Brainsway Valuation, Brainsway Correlation, Brainsway Hype Analysis, Brainsway Volatility, Brainsway History and analyze Brainsway Performance.
For more information on how to buy Brainsway Stock please use our How to Invest in Brainsway guide.

Brainsway Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Brainsway market risk premium is the additional return an investor will receive from holding Brainsway long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Brainsway. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Brainsway's performance over market.
α0.23   β1.24

Brainsway expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Brainsway's Buy-and-hold return. Our buy-and-hold chart shows how Brainsway performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Brainsway Market Price Analysis

Market price analysis indicators help investors to evaluate how Brainsway stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brainsway shares will generate the highest return on investment. By understating and applying Brainsway stock market price indicators, traders can identify Brainsway position entry and exit signals to maximize returns.

Brainsway Return and Market Media

The median price of Brainsway for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 9.5 with a coefficient of variation of 10.59. The daily time series for the period is distributed with a sample standard deviation of 0.97, arithmetic mean of 9.16, and mean deviation of 0.83. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
BrainsWay Rating Reiterated by HC Wainwright
09/20/2024
2
Brainsway Soars 14.5 percent Is Further Upside Left in the Stock
10/01/2024
3
Brainsway Ltd. Sponsored ADR Hits Fresh High Is There Still Room to Run
10/04/2024
4
Are Medical Stocks Lagging Brainsway This Year
10/15/2024
5
BrainsWay Ltd Trading 6.25 percent Higher on Oct 17
10/17/2024
6
Wall Street Analysts Believe Brainsway Could Rally 32.01 percent Heres is How to Trade
10/21/2024
7
Treace Medical Concepts versus BrainsWay Head to Head Contrast
10/28/2024
8
BrainsWay to Release Earnings on Tuesday
11/05/2024
9
FY2024 EPS Estimates for BrainsWay Increased by Analyst
11/14/2024
10
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
11/20/2024

About Brainsway Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Brainsway or other stocks. Alpha measures the amount that position in Brainsway has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding77.9365.0643.4141.24
PTB Ratio2.090.842.582.45

Brainsway Upcoming Company Events

As portrayed in its financial statements, the presentation of Brainsway's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brainsway's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Brainsway's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Brainsway. Please utilize our Beneish M Score to check the likelihood of Brainsway's management manipulating its earnings.
20th of March 2024
Upcoming Quarterly Report
View
15th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Brainsway

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Brainsway Stock Analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.